生物活性 | |||
---|---|---|---|
描述 | Diacerein, an anti-OA agent, can significantly inhibit IL-1β production. Both nitric oxide (NO) release and IL-1βsecretion induced by LPS could be reduced by treatment with 1μM Diacerein in human OA synovial tissue. Similar effect of Diacerein could be observed in LPS stimulated human cartilage in culture[1]. The synthesis of MMP-13 induced by IL-1β could be dose-dependently reduced by Diacerein at concentration of 10 and 20μg/ml in subchondral bone explants. Pre-incubation with diacerein for 2 hours with diacerein at 20 μg/mL led to inhibition of ERK1/2 and p38 pathways activated by IL-1β at concentration of 100 pg/mL for 30 minutes in the OA subchondral bone osteoblasts. Differentiation/proliferation of osteoclasts Raw 264.7 cells under RANKL treatment and IL-1β stimulation could be markedly inhibited by 20 μg/mL Diacerein[2]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.72mL 0.54mL 0.27mL |
13.58mL 2.72mL 1.36mL |
27.15mL 5.43mL 2.72mL |
参考文献 |
---|